Department of Vascular Surgery, First Hospital, China Medical University, Shenyang, China.
Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1825-31. doi: 10.1161/ATVBAHA.109.200303. Epub 2010 May 6.
Increasing evidence shows that autoimmune response contributes importantly to pathogenesis of abdominal aortic aneurysm (AAA). This work was aimed to assess the possibly altered function of peripheral CD4(+)CD25(+) T regulatory cells (Tregs) that might breakdown immunologic self-tolerance in AAA patients.
Peripheral blood from 22 AAA patients, 11 patients with abdominal aortic atherosclerotic occlusive disease (AOD), and 32 healthy controls (HCs) was analyzed to determine the percentage of CD4(+)CD25(+) Tregs in the total CD4(+) T-cell population and FOXP3 expression by means of flow cytometry. The frequencies of the CD4(+)CD25(+) Treg population were not significantly different between groups (AAA, 5.69+/-0.99%; AOD, 5.52+/-1.13%; HC, 5.88+/-1.55%; P>0.05). However, the frequency of CD4(+)CD25(+)FOXP3(+) T cells in AAA patients (2.45+/-0.57%) was significantly lower than that in AOD group (3.41+/-0.72%; P<0.01) or in HCs (3.69+/-0.82%; P<0.01). A comparison of FOXP3 mRNA and protein expression revealed significantly lower levels in CD4(+)CD25(+) Tregs from AAA group than either of other 2 groups (P<0.01). Suppressive function assay showed that freshly isolated CD4(+)CD25(+) Tregs from patients with AAA exhibited significantly less suppressive activity than those from AOD patients or HCs (P<0.01). Mixing cultures with CD4(+)CD25(+) T cells and CD4(+)CD25(-) T cells from AAA patients and HCs demonstrated that the primary regulatory defect is due to a dysfunction of CD4(+)CD25(+) Tregs, and not a resistance of CD4(+)CD25(-) responder T cells to suppression in AAA patients.
Our data demonstrate a reduced level of FOXP3 expression in peripheral CD4(+)CD25(+) Tregs and decreased frequency of CD4(+)CD25(+)FOXP3(+) T cells in a cohort of AAA patients enrolled in the study, which leads to a functional deficiency of CD4(+)CD25(+) Tregs as a whole. This indicates an impaired immunoregulation by Tregs that may contribute to AAA pathogenesis.
越来越多的证据表明,自身免疫反应对腹主动脉瘤(AAA)的发病机制有重要贡献。本研究旨在评估 AAA 患者外周血 CD4+CD25+调节性 T 细胞(Tregs)功能可能发生的改变,这些细胞可能破坏免疫耐受。
通过流式细胞术分析 22 例 AAA 患者、11 例腹主动脉粥样硬化性闭塞性疾病(AOD)患者和 32 例健康对照者(HCs)外周血中 CD4+CD25+Tregs 在总 CD4+T 细胞中的比例和 FOXP3 表达。各组间 CD4+CD25+Treg 群体的频率无显著差异(AAA 组为 5.69+/-0.99%;AOD 组为 5.52+/-1.13%;HCs 组为 5.88+/-1.55%;P>0.05)。然而,AAA 患者 CD4+CD25+FOXP3+T 细胞的频率(2.45+/-0.57%)明显低于 AOD 组(3.41+/-0.72%;P<0.01)或 HCs(3.69+/-0.82%;P<0.01)。比较 FOXP3 mRNA 和蛋白表达发现,AAA 组 CD4+CD25+Tregs 的表达水平明显低于其他两组(P<0.01)。抑制功能检测显示,AAA 患者新鲜分离的 CD4+CD25+Tregs 的抑制活性明显低于 AOD 患者或 HCs(P<0.01)。将 AAA 患者和 HCs 的 CD4+CD25+T 细胞和 CD4+CD25-T 细胞混合培养表明,主要的调节缺陷是由于 CD4+CD25+Tregs 功能障碍,而不是 AAA 患者 CD4+CD25-T 反应细胞对抑制的抵抗。
我们的数据表明,研究队列中的 AAA 患者外周血 CD4+CD25+Tregs 中 FOXP3 表达水平降低,CD4+CD25+FOXP3+T 细胞频率降低,导致 CD4+CD25+Tregs 整体功能缺陷。这表明 Tregs 的免疫调节受损可能导致 AAA 的发病机制。